These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Sortilin-related receptor CNS expressed 2 (SorCS2) is localized to Bunina bodies in amyotrophic lateral sclerosis. Mori F; Miki Y; Tanji K; Kakita A; Takahashi H; Utsumi J; Sasaki H; Wakabayashi K Neurosci Lett; 2015 Nov; 608():6-11. PubMed ID: 26420026 [TBL] [Abstract][Full Text] [Related]
23. SorLA deficiency dissects amyloid pathology from tau and cholinergic neurodegeneration in a mouse model of Alzheimer's disease. Capsoni S; Carlo AS; Vignone D; Amato G; Criscuolo C; Willnow TE; Cattaneo A J Alzheimers Dis; 2013; 33(2):357-71. PubMed ID: 22986780 [TBL] [Abstract][Full Text] [Related]
24. Activation and functional characterization of the mosaic receptor SorLA/LR11. Jacobsen L; Madsen P; Jacobsen C; Nielsen MS; Gliemann J; Petersen CM J Biol Chem; 2001 Jun; 276(25):22788-96. PubMed ID: 11294867 [TBL] [Abstract][Full Text] [Related]
25. Investigation of serum levels of sortilin in response to antidepressant treatment. Buttenschøn HN; Nielsen M; Glerup S; Mors O Acta Neuropsychiatr; 2018 Apr; 30(2):111-116. PubMed ID: 28478778 [TBL] [Abstract][Full Text] [Related]
34. Finding memo: versatile interactions of the VPS10p-Domain receptors in Alzheimer's disease. Salasova A; Monti G; Andersen OM; Nykjaer A Mol Neurodegener; 2022 Nov; 17(1):74. PubMed ID: 36397124 [TBL] [Abstract][Full Text] [Related]
35. Stigmoid bodies contain type I receptor proteins SorLA/LR11 and sortilin: new perspectives on their function. Gutekunst CA; Torre ER; Sheng Z; Yi H; Coleman SH; Riedel IB; Bujo H J Histochem Cytochem; 2003 Jun; 51(6):841-52. PubMed ID: 12754295 [TBL] [Abstract][Full Text] [Related]
36. SorLA and CLC:CLF-1-dependent Downregulation of CNTFRα as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry. Larsen JV; Petersen CM J Vis Exp; 2017 Jan; (119):. PubMed ID: 28117780 [TBL] [Abstract][Full Text] [Related]
37. Amyloid beta₁₋₄₂ (Aβ₄₂) up-regulates the expression of sortilin via the p75(NTR)/RhoA signaling pathway. Saadipour K; Yang M; Lim Y; Georgiou K; Sun Y; Keating D; Liu J; Wang YR; Gai WP; Zhong JH; Wang YJ; Zhou XF J Neurochem; 2013 Oct; 127(2):152-62. PubMed ID: 23895422 [TBL] [Abstract][Full Text] [Related]
38. LR11/SorLA links triglyceride-rich lipoproteins to risk of developing cardiovascular disease in FH patients. Vongpromek R; Bujo H; Hoekstra M; Schneider WJ; van der Zee L; Schinkel AF; Korporaal SJ; Dik WA; Ebinuma H; Jiang M; Verhoeven AJ; Sijbrands EJ; Mulder MT Atherosclerosis; 2015 Dec; 243(2):429-37. PubMed ID: 26520897 [TBL] [Abstract][Full Text] [Related]
39. Characterization of the VPS10 domain of SorLA/LR11 as binding site for the neuropeptide HA. Lintzel J; Franke I; Riedel IB; Schaller HC; Hampe W Biol Chem; 2002 Nov; 383(11):1727-33. PubMed ID: 12530537 [TBL] [Abstract][Full Text] [Related]
40. Circulating soluble LR11/SorLA levels are highly increased and ameliorated by chemotherapy in acute leukemias. Sakai S; Nakaseko C; Takeuchi M; Ohwada C; Shimizu N; Tsukamoto S; Kawaguchi T; Jiang M; Sato Y; Ebinuma H; Yokote K; Iwama A; Fukamachi I; Schneider WJ; Saito Y; Bujo H Clin Chim Acta; 2012 Oct; 413(19-20):1542-8. PubMed ID: 22750733 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]